PURE Bioscience, Inc. (PURE)

USD 0.06

(-14.29%)

Market Cap (In USD)

7.04 Million

Revenue (In USD)

1.96 Million

Net Income (In USD)

-3.35 Million

Avg. Volume

20.26 Thousand

Currency
USD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
0.06-0.16
PE
-
EPS
-
Beta Value
0.037
ISIN
US74621T2096
CUSIP
74621T209
CIK
1006028
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Mr. Robert F. Bartlett
Employee Count
-
Website
https://www.purebio.com
Ipo Date
1996-08-08
Details
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.